Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus

Cell Host and Microbe

Volumn 7, Issue 6, 2010, Pages 463-473

  Kretschmer, Dorothee ^a   Gleske, Anne Kathrin ^a   Rautenberg, Maren ^a   Wang, Rong ^b   Köberle, Martin ^a   Bohn, Erwin ^a   Schöneberg, Torsten ^c   Rabiet, Marie Joséphe ^d,e,f   Boulay, Francois ^d,e,f   Klebanoff, Seymour J ^g   Van Kessel, Kok A ^h   Van Strijp, Jos A ^h   Otto, Michael ^b   Peschel, Andreas ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d CEA GRENOBLE   (France)

^e CNRS   (France)

^f UNIV GRENOBLE ALPES   (France)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL TOXIN; FORMYL PEPTIDE RECEPTOR 2; FORMYLPEPTIDE RECEPTOR; PHENOL SOLUBLE MODULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 77956533710     PISSN: 19313128     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chom.2010.05.012     Document Type: Article

References (42)

1. Alvarez, V., Coto, E., Setién, F., González-Roces, S., and López-Larrea, C. (1996). Molecular evolution of the N-formyl peptide and C5a receptors in non-human primates. Immunogenetics 44, 446-452.
2. Bubeck Wardenburg, J., Bae, T., Otto, M., Deleo, F. R., and Schneewind, O. (2007). Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat. Med. 13, 1405-1406.
3. Chambers, H. F., and Deleo, F. R. (2009). Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7, 629-641.
4. Christophe, T., Karlsson, A., Dugave, C., Rabiet, M. J., Boulay, F., and Dahlgren, C. (2001). The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J. Biol. Chem. 276, 21585-21593.
5. Cui, Y., Le, Y., Yazawa, H., Gong, W., and Wang, J. M. (2002). Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J. Leukoc. Biol. 72, 628-635.
6. Dahlgren, C., Christophe, T., Boulay, F., Madianos, P. N., Rabiet, M. J., and Karlsson, A. (2000). The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A (4) receptor. Blood 95, 1810-1818.
7. de Haas, C. J., Veldkamp, K. E., Peschel, A., Weerkamp, F., Van Wamel, W. J., Heezius, E. C., Poppelier, M. J., Van Kessel, K. P., and van Strijp, J. A. (2004). Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J. Exp. Med. 199, 687-695.
8. Devosse, T., Guillabert, A., D'Haene, N., Berton, A., De Nadai, P., Noel, S., Brait, M., Franssen, J. D., Sozzani, S., Salmon, I., and Parmentier, M. (2009). Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils. J. Immunol. 182, 4974-4984.
9. Diep, B. A., and Otto, M. (2008). The role of virulence determinants in communityassociated MRSA pathogenesis. Trends Microbiol. 16, 361-369.
10. Diep, B. A., Palazzolo-Ballance, A. M., Tattevin, P., Basuino, L., Braughton, K. R., Whitney, A. R., Chen, L., Kreiswirth, B. N., Otto, M., DeLeo, F. R., and Chambers, H. F. (2008). Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS ONE 3, e3198.
11. Dürr, M. C., Kristian, S. A., Otto, M., Matteoli, G., Margolis, P. S., Trias, J., van Kessel, K. P., van Strijp, J. A., Bohn, E., Landmann, R., and Peschel, A. (2006). Neutrophil chemotaxis by pathogen-associated molecular patterns-formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus. Cell. Microbiol. 8, 207-217.
12. Elagoz, A., Henderson, D., Babu, P. S., Salter, S., Grahames, C., Bowers, L., Roy, M. O., Laplante, P., Grazzini, E., Ahmad, S., and Lembo, P. M. (2004). A truncated form of CKbeta8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor. Br. J. Pharmacol. 141, 37-46.
13. Foster, T. J. (2004). The Staphylococcus aureus "superbug". J. Clin. Invest. 114, 1693-1696.
14. Fu, H., Karlsson, J., Bylund, J., Movitz, C., Karlsson, A., and Dahlgren, C. (2006). Ligand recognition and activation of formyl peptide receptors in neutrophils. J. Leukoc. Biol. 79, 247-256.
15. Gao, J. L., Chen, H., Filie, J. D., Kozak, C. A., and Murphy, P. M. (1998). Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse. Genomics 51, 270-276.
16. Hartt, J. K., Barish, G., Murphy, P. M., and Gao, J. L. (1999). N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR. J. Exp. Med. 190, 741-747.
17. Hecht, I., Rong, J., Sampaio, A. L., Hermesh, C., Rutledge, C., Shemesh, R., Toporik, A., Beiman, M., Dassa, L., Niv, H., et al. (2009). A novel peptide agonist of formyl-peptide receptor-like 1 (ALX) displays anti-inflammatory and cardioprotective effects. J. Pharmacol. Exp. Ther. 328, 426-434.
18. Kahl, B. C., and Peters, G. (2007). Microbiology. Mayhem in the lung. Science 315, 1082-1083.
19. Kalmar, J. R., and Van Dyke, T. E. (1994). Effect of bacterial products on neutrophil chemotaxis. Methods Enzymol. 236, 58-87.
20. Karin, M., Lawrence, T., and Nizet, V. (2006). Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124, 823-835.
21. Karlsson, J., Fu, H., Boulay, F., Bylund, J., and Dahlgren, C. (2006). The peptide Trp-Lys-Tyr-Met-Val-D-Met activates neutrophils through the formyl peptide receptor only when signaling through the formylpeptide receptor like 1 is blocked. A receptor switch with implications for signal transduction studies with inhibitors and receptor antagonists. Biochem. Pharmacol. 71, 1488-1496.
22. Le, Y., Murphy, P. M., and Wang, J. M. (2002). Formyl-peptide receptors revisited. Trends Immunol. 23, 541-548.
23. Leulier, F., and Lemaitre, B. (2008). Toll-like receptors-taking an evolutionary approach. Nat. Rev. Genet. 9, 165-178.
24. Mader, D., Rabiet, M. J., Boulay, F., and Peschel, A. (2010). Formyl peptide receptor-mediated proinflammatory consequences of peptide deformylase inhibition in Staphylococcus aureus. Microbes Infect. 12, 415-419.
25. Migeotte, I., Riboldi, E., Franssen, J. D., Grégoire, F., Loison, C., Wittamer, V., Detheux, M., Robberecht, P., Costagliola, S., Vassart, G., et al. (2005). Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J. Exp. Med. 201, 83-93.
26. Migeotte, I., Communi, D., and Parmentier, M. (2006). Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev. 17, 501-519.
27. Murphy, P. M., Ozçelik, T., Kenney, R. T., Tiffany, H. L., McDermott, D., and Francke, U. (1992). A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. J. Biol. Chem. 267, 7637-7643.
28. Onnheim, K., Bylund, J., Boulay, F., Dahlgren, C., and Forsman, H. (2008). Tumour necrosis factor (TNF)-alpha primes murine neutrophils when triggered via formyl peptide receptor-related sequence 2, the murine orthologue of human formyl peptide receptor-like 1, through a process involving the type I TNF receptor and subcellular granule mobilization. Immunology 125, 591-600.
29. Palazzolo-Ballance, A. M., Reniere, M. L., Braughton, K. R., Sturdevant, D. E., Otto, M., Kreiswirth, B. N., Skaar, E. P., and DeLeo, F. R. (2008). Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus. J. Immunol. 180, 500-509.
30. Perretti, M., Chiang, N., La, M., Fierro, I. M., Marullo, S., Getting, S. J., Solito, E., and Serhan, C. N. (2002). Endogenous lipid-and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat. Med. 8, 1296-1302.
31. Prat, C., Bestebroer, J., de Haas, C. J., van Strijp, J. A., and van Kessel, K. P. (2006). A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1. J. Immunol. 177, 8017-8026.
32. Queck, S. Y., Jameson-Lee, M., Villaruz, A. E., Bach, T. H., Khan, B. A., Sturdevant, D. E., Ricklefs, S. M., Li, M., and Otto, M. (2008). RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol. Cell 32, 150-158.
33. Queck, S. Y., Khan, B. A., Wang, R., Bach, T. H., Kretschmer, D., Chen, L., Kreiswirth, B. N., Peschel, A., Deleo, F. R., and Otto, M. (2009). Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA. PLoS Pathog. 5, e1000533.
34. Saïd-Salim, B., Mathema, B., and Kreiswirth, B. N. (2003). Communityacquired methicillin-resistant Staphylococcus aureus: an emerging pathogen. Infect. Control Hosp. Epidemiol. 24, 451-455.
35. Shopsin, B., Drlica-Wagner, A., Mathema, B., Adhikari, R. P., Kreiswirth, B. N., and Novick, R. P. (2008). Prevalence of agr dysfunction among colonizing Staphylococcus aureus strains. J. Infect. Dis. 198, 1171-1174.
36. Somerville, G. A., Cockayne, A., Dürr, M., Peschel, A., Otto, M., and Musser, J. M. (2003). Synthesis and deformylation of Staphylococcus aureus deltatoxin are linked to tricarboxylic acid cycle activity. J. Bacteriol. 185, 6686-6694.
37. Southgate, E. L., He, R. L., Gao, J. L., Murphy, P. M., Nanamori, M., and Ye, R. D. (2008). Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils. J. Immunol. 181, 1429-1437.
38. Styrt, B. (1989). Species variation in neutrophil biochemistry and function. J. Leukoc. Biol. 46, 63-74.
39. Su, S. B., Gong, W., Gao, J. L., Shen, W., Murphy, P. M., Oppenheim, J. J., and Wang, J. M. (1999). A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189, 395-402.
40. Uematsu, S., and Akira, S. (2006). Toll-like receptors and innate immunity. J. Mol. Med. 84, 712-725.
41. Wang, R., Braughton, K. R., Kretschmer, D., Bach, T. H., Queck, S. Y., Li, M., Kennedy, A. D., Dorward, D. W., Klebanoff, S. J., Peschel, A., et al. (2007). Identification of novel cytolytic peptides as key virulence determinants for communityassociated MRSA. Nat. Med. 13, 1510-1514.
42. Ye, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C., Parmentier, M., Serhan, C. N., and Murphy, P. M. (2009). International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol. Rev. 61, 119-161.